These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38949885)

  • 41. Are Observational Reports on the Association of Dialysate Sodium with Mortality Enough to Change Practice? Perspective from the RESOLVE Study Team.
    Smyth B; Krishnasamy R; Jardine M;
    J Am Soc Nephrol; 2024 Feb; 35(2):229-231. PubMed ID: 38096088
    [No Abstract]   [Full Text] [Related]  

  • 42. Drugs as a hidden source of aluminium for chronic renal patients.
    Bohrer D; Bertagnolli DC; de Oliveira SM; do Nascimento PC; de Carvalho LM; Pomblum SG
    Nephrol Dial Transplant; 2007 Feb; 22(2):605-11. PubMed ID: 17035374
    [No Abstract]   [Full Text] [Related]  

  • 43. Calcium balance in dialysis is best managed by adjusting dialysate calcium guided by kinetic modeling of the interrelationship between calcium intake, dose of vitamin D analogues and the dialysate calcium concentration.
    Gotch F; Levin NW; Kotanko P
    Blood Purif; 2010; 29(2):163-76. PubMed ID: 20093823
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interdialytic weight gain and low dialysate sodium concentration in patients on chronic hemodialysis: a systematic review and meta-analysis.
    Bossola M; Mariani I; Sacco M; Antocicco M; Pepe G; Di Stasio E
    Int Urol Nephrol; 2024 Jul; 56(7):2313-2323. PubMed ID: 38446246
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dialysate Sodium: Choosing the Optimal Hemodialysis Bath.
    Munoz Mendoza J; Arramreddy R; Schiller B
    Am J Kidney Dis; 2015 Oct; 66(4):710-20. PubMed ID: 25987259
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cost-effective dialysis for the developing world.
    Gregory MC
    Ethn Dis; 2009; 19(1 Suppl 1):S1-65-7. PubMed ID: 19484879
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The dual blockade of the renin-angiotensin system in hemodialysis patients requires decreased dialysate sodium concentration.
    Zwiech R; Bruzda-Zwiech A
    Int Urol Nephrol; 2013 Oct; 45(5):1365-72. PubMed ID: 23136031
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reducing complications during hemodialysis using gradient ultrafiltration with gradient sodium dialysate.
    Meers C; Toffelmire EB; McMurray M; Hopman W
    ANNA J; 1999 Oct; 26(5):495-500; discussion 501, 505. PubMed ID: 10776077
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dialysate copeptin and peritoneal transport in incident peritoneal dialysis patients.
    Fijałkowski M; Safranow K; Lindholm B; Ciechanowski K; Muraszko AM; Dołęgowska B; Dołęgowska K; Golembiewska E
    Int Urol Nephrol; 2019 Sep; 51(9):1667-1673. PubMed ID: 31187425
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Treatment of electrolyte disorders by hemodialysis].
    Galli D; Staffolani E; Miani N; Morosetti M; Di Daniele N
    G Ital Nefrol; 2011; 28(4):408-15. PubMed ID: 21809310
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sodium balance in maintenance hemodialysis.
    Santos SF; Peixoto AJ
    Semin Dial; 2010; 23(6):549-55. PubMed ID: 21175831
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The link between dialysate and chronic inflammatory disease in hemodialysis.
    Amato RL
    Nephrol Nurs J; 2002 Oct; 29(5):490-2. PubMed ID: 12434456
    [No Abstract]   [Full Text] [Related]  

  • 53. Clinical use of continuous blood volume monitoring.
    Lopot F
    EDTNA ERCA J; 1996; 22(4):7-11. PubMed ID: 10723339
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Optimum calcium concentration in the dialysate].
    Nakazawa R
    Clin Calcium; 2004 Sep; 14(9):84-7. PubMed ID: 15577117
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sodium setpoint and sodium gradient: influence on plasma sodium change and weight gain.
    Hecking M; Kainz A; Hörl WH; Herkner H; Sunder-Plassmann G
    Am J Nephrol; 2011; 33(1):39-48. PubMed ID: 21160174
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Do not forget to individualize dialysate sodium prescription.
    Lomonte C; Basile C
    Nephrol Dial Transplant; 2011 Apr; 26(4):1126-8. PubMed ID: 21372263
    [No Abstract]   [Full Text] [Related]  

  • 57. Do interleukin-6, hyaluronan, soluble intercellular adhesion molecule-1 and cancer antigen 125 in dialysate predict changes in peritoneal function? A 1-year follow-up study.
    Martikainen T; Ekstrand A; Honkanen E; Teppo AM; Grönhagen-Riska C
    Scand J Urol Nephrol; 2005; 39(5):410-6. PubMed ID: 16257844
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relationship between effective ionic dialysance and in vivo urea clearance during hemodialysis.
    Lindsay RM; Bene B; Goux N; Heidenheim AP; Landgren C; Sternby J
    Am J Kidney Dis; 2001 Sep; 38(3):565-74. PubMed ID: 11532690
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dialysate Sodium: Rationale for Evolution over Time.
    Flythe JE; Mc Causland FR
    Semin Dial; 2017 Mar; 30(2):99-111. PubMed ID: 28066913
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effects of glucose-free and glucose-containing dialysate during dialysis in MHD patients: a prospective cross-over study.
    Li M; Li Y; Lv J; Xu H; Wu X; Wen W; Wang W; Yang H
    Perfusion; 2023 Jan; 38(1):178-185. PubMed ID: 34541941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.